zopapogene imadenovec

FDA Drug Profile — PAPZIMEOS

Drug Details

Generic Name
zopapogene imadenovec
Brand Names
PAPZIMEOS
Application Number
BLA125832
Sponsor
Precigen, Inc.
NDC Codes
1
Dosage Forms
INJECTION, SUSPENSION
Routes
SUBCUTANEOUS
Active Ingredients
ZOPAPOGENE IMADENOVEC

Indications and Usage

1 INDICATIONS AND USAGE PAPZIMEOS is indicated for the treatment of adults with recurrent respiratory papillomatosis. PAPZIMEOS™ is a non-replicating adenoviral vector-based immunotherapy indicated for the treatment of adults with recurrent respiratory papillomatosis. ( 1 )